SCHEMBL5427704

SCHEMBL5427704

CS(=O)(=O)NCc1c[nH]c(=O)[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104935 0.78 ATAD2 (0.47) ATAD2
SCHEMBL22762949 0.74 ALDH1A1 (0.47) ATAD2KDM4EHSD17B10
SCHEMBL161148 0.73 ATAD2 (0.54) ATAD2MAPT
SCHEMBL3699779 0.72 DPYD (0.43) ATAD2MAPT
SCHEMBL28991875 0.71 GAA (0.46) MAPT
SCHEMBL30677850 0.71 LMNA (0.38) —
SCHEMBL4353311 0.71 DPYD (0.50) ATAD2MAPT
SCHEMBL5800398 0.71 — —
SCHEMBL11149023 0.70 ATAD2 (0.39) ATAD2
SCHEMBL31236144 0.70 DPYD (0.45) ATAD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447454-B2 Method of purifying RNA binding protein-RNA complexes THE ROCKEFELLER UNIVERSITY (US) 2016-09-20 — — US disclosed
US-20140378316-A1 METHOD OF PURIFYING RNA BINDING PROTEIN-RNA COMPLEXES THE ROCKEFELLER UNIVERSITY (US) 2014-12-25 — — US disclosed
US-7268218-B2 Cardiovascular system associated protein kinase 3 (CSAPK-3) antibodies MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-09-11 — — US disclosed
WO-2005041884-A2 POLYMER-BASED MICROSTRUCTURES ENGINEERED RELEASE SYSTEMS, INC (US) 2005-05-12 — — WO disclosed
US-20050027108-A1 Novel protein kinase molecules and uses therefor MILLENNIUM PHARMACEUTICALS, INC. 2005-02-03 — — US disclosed
WO-2002053728-A9 GENE DISRUPTION METHODOLOGIES FOR DRUG TARGET DISCOVERY ELITRA PHARMACEUTICALS INC (US) 2003-05-30 — — WO disclosed
WO-2002080968-A1 GLYCOPROTEIN VI AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-17 — — WO disclosed
WO-2001044476-A2 MOSS GENES FROM PHYSCOMITRELLA PATENS ENCODING PROTEINS INVOLVED IN THE SYNTHESIS OF CARBOHYDRATES BASF PLANT SCIENCE GMBH (DE) 2001-06-21 — — WO disclosed
Send feedback